Survival of Lupus patients cannot be accurately predicted due to individual differences. Generally speaking, as long as the patient receives active treatment, Lupus patients can achieve long-term survival, with a 10-year survival rate of about 90% and a 15-year survival rate of 80%. However, it is important to note that individual survival cannot be effectively assessed due to differences in patient’s physical condition, treatment regimen, and medical condition. When lupus erythematosus is in the active stage, patients tend to die from infections, organ damage, etc., while if they are in remission, they may die from chronic renal insufficiency, hormonal side effects and pulmonary hypertension. Therefore, it is recommended to have regular checkups during the treatment period, and to seek immediate medical treatment if any unexpected situation occurs. Patients with lupus erythematosus are advised to go to the rheumatology and immunology departments of regular hospitals for detailed consultation, follow the doctor’s instructions to standardize the diagnosis and treatment, and review the relevant indexes regularly at the same time.